Skip to content
HowShorted

Altimmune, Inc. short interest in 2021

In 2021, Altimmune, Inc.'s disclosed short interest ran from 7.86% of shares outstanding on 15 Jan 2021 to 11.29% on 31 Dec 2021, a change of +3.43 percentage points. The year's high was 16.76% on 15 Sep 2021 and its low 6.50% on 26 Feb 2021, averaging 12.12% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.49 days on 14 May 2021. Full history: Altimmune, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Altimmune, Inc. in 2021

2021 in figures

Start of year
7.86% (15 Jan 2021)
End of year
11.29% (31 Dec 2021)
Change
+3.43 pp
High
16.76% (15 Sep 2021)
Low
6.50% (26 Feb 2021)
Average
12.12%
Highest days to cover
7.49 (14 May 2021)
SEC filings marked
8

Every report in 2021

Altimmune, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20217.86%2.18
29 Jan 20217.89%1.41
12 Feb 20217.63%1.29
26 Feb 20216.50%1.5810-K filed, results (8-K)
15 Mar 20217.99%2.20
31 Mar 202114.58%3.47
15 Apr 202113.04%6.87
30 Apr 202113.59%5.78
14 May 202114.16%7.49
28 May 202111.38%4.2710-Q filed, results (8-K)
15 Jun 202111.34%3.86
30 Jun 202112.48%1.00
15 Jul 202114.17%2.45
30 Jul 202113.47%6.67
13 Aug 202113.23%4.4910-Q filed, results (8-K)
31 Aug 202116.06%5.52
15 Sep 202116.76%4.66
30 Sep 202115.43%2.20
15 Oct 202114.40%7.27
29 Oct 202114.12%7.42
15 Nov 202111.98%5.7010-Q filed, results (8-K)
30 Nov 202110.85%6.85
15 Dec 202110.78%5.62
31 Dec 202111.29%5.18

See also: Altimmune, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.